New multitarget agents show potent enzyme inhibition and improved glucose uptake, indicating potential for diabetes treatment.
New pyrazole/oxazole sulfaguanidine-hydrazone hybrids demonstrate potent dual α-glucosidase/α-amylase inhibition and enhanced glucose uptake, with docking studies revealing key enzyme interactions.
No takes yet. Share an insight, caveat, or question.
Ayoup et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: